Telmisartan preparation method and intermediate of telmisartan

A kind of technology of telmisartan and compound, applied in the field of preparation of intermediate

Inactive Publication Date: 2014-05-14
TOPHARMAN SHANGHAI +2
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The above synthetic methods are two-step, and there is still the possibility of further simplifying the process and reducing the cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Telmisartan preparation method and intermediate of telmisartan
  • Telmisartan preparation method and intermediate of telmisartan
  • Telmisartan preparation method and intermediate of telmisartan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] Example 1: Preparation of 4'-chloromethylbiphenyl-2-carboxylic acid (II, R=COOH, X=Cl)

[0105] Add 4'-methylbiphenyl 2-carboxylic acid (IV) (10g, 0.047mol), azobisisobutylcyanide (AIBN) (0.11g, 1.5mol%) into chlorobenzene (35mL), stir, Heat to 90°C, slowly add SO 2 Cl 2 (3.8mL, 0.047mol) of chlorobenzene solution (15mL), after the dropwise addition, stir for 1 hour, and TLC detects that the reaction is over; the reaction solution is naturally cooled to room temperature, and solids are precipitated, then cooled in an ice bath for 1 hour, and suction filtered , the obtained filtrate was washed with toluene (10mL×2), and dried to obtain white granular solid II (9.5g, yield 82%). 1 H NMR (300MHz, DMSO-d6): 12.79 (s, 1H, OH), 7.21-7.75 (m, 8H, ArH), 4.81 (s, 2H, CH2), MS: 246.1.

Embodiment 2

[0106] Example 2: Preparation of 4'-chloromethylbiphenyl-2-carboxylic acid (II, R=COOH, X=Cl)

[0107] Add 4'-methylbiphenyl 2-carboxylic acid (IV) (10g, 0.047mol), azobisisobutylcyanide (AIBN) (0.11g, 1.5mol%) into chlorobenzene (70mL), stir, Heat to 80°C, add trichloroisocyanuric acid (10.9g, 0.047mol), stir for 12 hours, and filter out the insoluble matter; naturally cool the reaction solution to room temperature, and solids are precipitated, and the obtained filtrate is washed with toluene ( 10mL×2), dried to obtain white granular solid II (6g, yield 52%).

Embodiment 3

[0108] Example 3: Preparation of 4'-chloromethylbiphenyl-2-carboxylic acid (II, R=COOH, X=Cl)

[0109] Dissolve 4'-methylbiphenyl 2-carboxylic acid (IV) (10g, 0.047mol) in dichloromethane (150mL), add benzoyl peroxide (0.23g, 2mol%), add 1.1 equivalent of chlorine, The reaction was stirred for 12 hours; saturated aqueous sodium bicarbonate solution was added to the reaction solution for extraction, the organic layer was separated, and the solvent was evaporated to dryness to obtain off-white solid II (6 g, yield 52%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a telmisartan preparation method. The telmisartan preparation method is characterized in that 2-n-propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole (compound I) and 4'-halomethyl diphenyl-2-substituted compound (compound II) carry out a nucleophilic substitution reaction to obtain a compound III; when R is COOH, the compound III is telmisartan; when R is COOR' or CN, the compound III is hydrolyzed to obtain the telmisartan.

Description

technical field [0001] The present invention relates to a preparation method of an antihypertensive drug Telmisartan (Telmisartan) and its intermediate, and also relates to a preparation method of these intermediates. Background technique [0002] Telmisartan is a new type of non-peptide angiotensin II (AT II) receptor antagonist, clinically used in the treatment of hypertension, its chemical name is 4'-[(1,4'-dimethyl-2 '-Propyl[2,6'-di-1H-benzimidazole]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid, the structure is as follows: [0003] [0004] The existing synthetic route of telmisartan mainly uses 3-methyl-4-aminobenzoic acid methyl ester as the starting material to obtain the intermediate through N-acylation, nitration, reduction, cyclization, ester hydrolysis, and condensation reactions. 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole (I), I and 4'-bromomethylbiphenyl-2-carboxylic acid tert-butyl The ester (V) undergoes a two-step reaction of nuc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D235/18C07C63/72C07C51/363C07C255/50C07C253/30C07C69/65C07C67/307
CPCC07C69/76C07C63/06C07C63/72C07D235/18C07C51/363C07C67/307C07C69/65C07C253/30C07C255/50
Inventor 吴明军李剑峰陈伟铭田广辉朱富强索瑾沈敬山
Owner TOPHARMAN SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap